ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Direct costs attributable to producing goods sold
5Y CAGR
+7.7%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $20.42M | -0.7% |
| 2024 | $20.56M | - |
| 2023 | $0.00 | - |
| 2022 | $0.00 | -100.0% |
| 2021 | $213000.00 | -98.5% |
| 2020 | $14.07M | +810.1% |
| 2019 | $1.55M | +8.9% |
| 2018 | $1.42M | - |